XML 49 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Income (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Net sales $ 499,672 $ 486,277
Cost of goods sold 228,260 207,695
Gross profit 271,412 278,582
Selling, general and administrative expense 185,917 171,293
Research and development expense 51,941 52,923
Segment profit (loss) 33,554 54,366
Interest expense 10,977 13,196
Foreign exchange losses, net 1,528 1,441
Other (income) expense, net (1,400) (6,450)
Income before income taxes 22,449 46,179
Provision for income taxes (2,929) (15,235)
Net income including noncontrolling interests 19,520 30,944
Net loss (income) attributable to noncontrolling interests (21) 61
Net income attributable to Bio-Rad $ 19,499 $ 31,005
Basic earnings per share:    
Net income per share basic attributable to Bio-Rad $ 0.68 $ 1.10
Weighted average common shares - basic 28,494 28,201
Diluted earnings per share:    
Net income per share diluted attributable to Bio-Rad $ 0.68 $ 1.09
Weighted average common shares - diluted 28,817 28,553